Inhibitor Therapeutics INTI
OTC INTI
$0.08 +0.00 (+0.00%)
At close: Nov 6, 2026 · 4:00 PM EST

Inhibitor Therapeutics (INTI) Common Stock Issued (2014 - 2016)

Updated

Analysis

Inhibitor Therapeutics (INTI) Common Stock Issued (2014 - 2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Issued (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 743.00 Mn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 247.00 Mn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 87.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Inhibitor Therapeutics 13.90 Mn 6.72 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 4.54 Mn
Dec 31, 2014 550,000.00
Sep 30, 2014 550,000.00
API Access

Inhibitor Therapeutics Common Stock Issued API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-stock-issued&ticker=INTI&period=max&api_key=YOUR_API_KEY